Abhydrolase domain containing 13, abbreviated as ABHD13, is an enzyme that belongs to a larger family of proteins characterized by their abhydrolase domain, which includes esterases, lipases, and peptidases. This domain is responsible for hydrolytic activity, typically involving the cleavage of ester bonds in various substrates, which is crucial for a multitude of metabolic and signaling processes within cells.
While the specific physiological role of ABHD13 is not yet fully understood, proteins containing the abhydrolase domain are known to participate in the metabolism of lipids, which are essential components of cell membranes and play a role as signaling molecules. The potential enzymatic activity of ABHD13 suggests it may contribute to the regulation of lipid-mediated pathways that impact cellular functions such as signal transduction, energy balance, and membrane dynamics.The study of ABHD13's expression patterns across different tissues may offer insight into its biological significance. For instance, a protein expressed predominantly in lipid-rich tissues like the brain or adipose tissues could be implicated in lipid metabolism or signaling in those specific contexts. Conversely, a ubiquitous expression pattern could indicate a fundamental role in general cellular maintenance.
SEE ALSO...
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, potentially increasing cAMP levels and influencing ABHD13 activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that can mimic the effect of elevated cAMP, possibly affecting ABHD13 indirectly. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C, which could modulate ABHD13 activity through phosphorylation pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that can alter intracellular calcium levels, potentially affecting ABHD13. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor, could indirectly influence ABHD13 expression and activity. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
As a sirtuin inhibitor, it may have an impact on ABHD13 activity through epigenetic regulation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound with various cellular effects, potentially influencing ABHD13 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to affect a variety of signaling pathways, possibly impacting ABHD13 indirectly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences glycogen synthase kinase 3-beta (GSK-3β) signaling, potentially impacting ABHD13. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could indirectly affect ABHD13 activity through cellular growth and metabolism pathways. | ||||||